Penson RT - Search Results

1

Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240).

Penson RT, Huang HQ, Wenzel LB, Monk BJ, Stockman S, Long HJ 3rd, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Method M, Michael H, Tewari KS. Penson RT, et al. Lancet Oncol. 2015 Mar;16(3):301-11. doi: 10.1016/S1470-2045(15)70004-5. Epub 2015 Jan 29. Lancet Oncol. 2015. PMID: 25638326 Free PMC article. Clinical Trial.

2

Progress in gynecologic oncology.

Penson RT, Seiden MV. Penson RT, et al. Oncologist. 1999;4(4):293-8. Oncologist. 1999. PMID: 10476540 Free article. No abstract available.

3

Efficacy and hematologic toxicity of salvage chemotherapy following stem cell-supported high-dose chemotherapy in women with recurrent ovarian cancer.

Cook S, Penson R, Duska L, Nikrui N, Goodman A, Fuller A, Seiden M. Cook S, et al. Gynecol Oncol. 2000 Apr;77(1):48-54. doi: 10.1006/gyno.1999.5710. Gynecol Oncol. 2000. PMID: 10739690

4

A Phase I-II study of 96-hour infusional topotecan and paclitaxel for patients with recurrent Müllerian tumors.

Penson RT, Supko JG, Seiden MV, Fuller AF, Berkowitz RS, Goodman A, Campos SM, MacNeill KM, Cook S, Matulonis UA. Penson RT, et al. Cancer. 2001 Sep 1;92(5):1156-67. doi: 10.1002/1097-0142(20010901)92:5<1156::aid-cncr1434>3.0.co;2-g. Cancer. 2001. PMID: 11571729 Clinical Trial.

5

Paclitaxel and platinum chemotherapy for malignant mixed müllerian tumors of the ovary.

Duska LR, Garrett A, Eltabbakh GH, Oliva E, Penson R, Fuller AF. Duska LR, et al. Gynecol Oncol. 2002 Jun;85(3):459-63. doi: 10.1006/gyno.2002.6645. Gynecol Oncol. 2002. PMID: 12051874

6

Phase II study of liposomal doxorubicin and weekly paclitaxel for recurrent Müllerian tumors.

Campos SM, Matulonis UA, Penson RT, Lee H, Berkowitz RS, Duska LR, Fuller AF Jr, Wilson KS, Puchalski TA, Supko JG, Seiden MV. Campos SM, et al. Among authors: penson rt. Gynecol Oncol. 2003 Sep;90(3):610-8. doi: 10.1016/s0090-8258(03)00373-1. Gynecol Oncol. 2003. PMID: 13678734 Clinical Trial.

7

Phase II trial of anastrozole in women with asymptomatic müllerian cancer.

del Carmen MG, Fuller AF, Matulonis U, Horick NK, Goodman A, Duska LR, Penson R, Campos S, Roche M, Seiden MV. del Carmen MG, et al. Gynecol Oncol. 2003 Dec;91(3):596-602. doi: 10.1016/j.ygyno.2003.08.021. Gynecol Oncol. 2003. PMID: 14675683 Clinical Trial.

8

Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples.

Penson RT, Oliva E, Skates SJ, Glyptis T, Fuller AF Jr, Goodman A, Seiden MV. Penson RT, et al. Gynecol Oncol. 2004 Apr;93(1):98-106. doi: 10.1016/j.ygyno.2003.11.053. Gynecol Oncol. 2004. PMID: 15047220

9

Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with müllerian malignancies.

Penson RT, Seiden MV, Goodman A, Fuller AF Jr, Berkowitz RS, Matulonis UA, Krasner C, Lee H, Atkinson T, Campos SM; Gynecologic Oncology Research Program at Dana Farber/Partners CancerCare. Penson RT, et al. Gynecol Oncol. 2004 Jun;93(3):702-7. doi: 10.1016/j.ygyno.2004.02.028. Gynecol Oncol. 2004. PMID: 15196868 Clinical Trial.

10

Attitudes to chemotherapy in patients with ovarian cancer.

Penson RT, Dignan F, Seiden MV, Lee H, Gallagher CJ, Matulonis UA, Olson K, Gibbens I, Gore ME. Penson RT, et al. Gynecol Oncol. 2004 Aug;94(2):427-35. doi: 10.1016/j.ygyno.2004.05.034. Gynecol Oncol. 2004. PMID: 15297184

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

192 results

Search Page

Filters